The Global Health Body Issues Alert Over Critical Shortage of Obesity Medications

Under 10% of people that would benefit from weight-loss injections like Wegovy have access to them, caution the global health agency as it releases its inaugural guidance on the drugs.

With over a billion individuals worldwide currently living with obesity, it is urging broader and more equitable access to these injectable treatments.

Based on estimates, more than two billion could be obese by 2030 if no action is taken.

"Our latest guidance affirms that obesity is a long-term condition that can be treated with thorough and continuous support," said WHO director-general Tedros Adhanom Ghebreyesus.

High costs, insufficient output, and logistical bottlenecks are major obstacles to broad availability to the injections that can assist patients in reducing significant weight, explains the body.

Skinny Jab Scarcity

Despite the present best projected case, the manufacturing of these medications could only cover around 100 million people – less than 10% of the global need, as stated by the health organization.

The recommendation encourages countries and companies to increase access, by approaches such as voluntary licensing.

The intellectual property rights on semaglutide – the primary ingredient of the drug Wegovy – is scheduled to end in several countries in 2026.

The Way Weight-Loss Jabs Function

GLP-1 drugs imitate a biological compound to reduce digestion speed, curb appetite and enhance satiety so individuals eat less.

Individuals usually see weight reduction after several weeks of commencing the regular doses.

Studies suggests patients may regain a significant portion within a year of halting the medication, when their typical appetite return.

To be above a healthy weight raises your likelihood for experiencing health problems, including type 2 diabetes, heart disease, brain attack, and some cancers.

Excess weight affects individuals in countries worldwide and was associated with over three and a half million fatalities worldwide in 2024, as per the health agency.